Capital Ideas
DigestGet Premium


10 Dividend All-Stars for 2019

Also inside: New analyst coverage of two cannabis companies. One’s a leader in extraction with 100%+ upside, the other a best-in-class multi-state operator. Plus: Three stocks that could keep going higher.

Tech Company Returning to Growth with 80% Upside

Also inside: Top U.S. hemp-based CBD seller an established leader at the right time. Plus: Gold company could be acquisition target with projected return of 73%.

Fast-Growth, Cash-Rich & Low Risk with 25% Upside

Also inside: New analyst coverage of cobalt and gold plays with projected returns of nearly 80% and 130%. Plus: This software stock has broken out after building a base for four years.

KeyStone Research on Global Cannabis Candidates

Also inside: New coverage of a U.S. marijuana player that has 109% upside. Plus: Four stock ideas for the new four-year market cycle.

Five High-Growth, Catalyst-Rich Small Cap Top Picks

Also inside: New coverage of a multi-faceted U.S. cannabis company with 50% upside. Plus: Three Canadian top picks offering growth and value.

Best Ideas of 2019 from Our All-Star Contributors

Inside: 12 hand-selected stock picks from the likes of Fabrice Taylor, Ryan Irvine, Peter Hodson, Roger Dent and more. Plus: Dwight Galusha’s favorite chart set up for this year.

E-Commerce Operator Outperforming Amazon

Also inside: New coverage of a “high conviction” Canadian health care technology company. Plus: Our best and worst ideas of 2018.

Biotech Could Surge 245% on Manmade CBD Drug

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.

Error X
Your e-mails don't match.